Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Cash from Investing Activities

Aerie Pharmaceuticals Cash from Investing Activities Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Cash from Investing Activities from 2012 to 2020.
  • Aerie Pharmaceuticals Cash from Investing Activities for the quarter ending June 06, 2020 was $40m a 346.82% increase of 138m year over year
  • Aerie Pharmaceuticals Cash from Investing Activities for the last 12 months ending June 06, 2020 was $-103m a -3.08% increase of 3m year over year
  • Aerie Pharmaceuticals Annual Cash from Investing Activities for 2019 was $-183m a 111.34% decrease of -204m from 2018
  • Aerie Pharmaceuticals Annual Cash from Investing Activities for 2018 was $21m a 305.91% increase of 64m from 2017
  • Aerie Pharmaceuticals Annual Cash from Investing Activities for 2017 was $-43m a 142.28% decrease of -61m from 2016
Other Cash Flow Metrics:
  • Aerie Pharmaceuticals Cash Flow from Operations for the quarter ending September 09, 2018 was $-43m a 39.56% decrease of -17m year over year
  • Aerie Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-29m a -53.21% increase of 16m year over year
  • Aerie Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $7m
View Chart On Koyfin

Quarterly AERI Cash from Investing Activities Data

06/2020$40m
03/2020$33m
12/2019$-78m
09/2019$-98m
06/2019$-2m
03/2019$-5m
12/2018$-1m
09/2018$8m
06/2018$55m
03/2018$-42m

Annual AERI Cash from Investing Activities Data

2019$-183m
2018$21m
2017$-43m
2016$18m
2015$9m
2014$-73m
2013$0m
2012$0m
2011$0m